Back to search

Article

In-silico analysis of nsSNPs in human CYP3A4/5 and their effects on drug-enzymes interactions of FDA-approved COVID-19 antiviral drugs: A pharmacogenetic study

2024-02-13

Abstract excerpt

<title>Abstract</title> <p>Single nucleotide polymorphisms (SNPs) represent the prevailing form of genetic variations observed in the human population. Such variations could alter the encoded enzymes’ activities. CYP3A4/5 enzymes have a pivotal role in metabolising drugs, notably antivirals against SARS-CoV-2. In this work we computationally investigated antiviral-enzyme interactions of CYP3A4/5 genetic variants....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73d44543-f4e2-5893-a723-79e6c3f5d73c
DOI
10.21203/rs.3.rs-3910067/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In-silico analysis of nsSNPs in human CYP3A4/5 and their effects on drug-enzymes interactions of FDA-approved COVID-19 antiviral drugs: A pharmacogenetic studyDOI 10.21203/rs.3.rs-3910067/v1
Select a neighboring publication to make it the new centre.